BridgeBio shares KRAS data; Hutchmed’s Phase 3 success in Chinanews2026-01-07T15:26:03+00:00January 7th, 2026|Endpoints News|
Poplar Therapeutics gets $50M Series A for immunology ambitionsnews2026-01-07T14:45:13+00:00January 7th, 2026|Endpoints News|
GSK, Ionis say they may have a cure for some hepatitis B patients after Phase 3 winnews2026-01-07T14:42:45+00:00January 7th, 2026|Endpoints News|
Lilly partners with protein mapping startup InduPro for up to $950Mnews2026-01-07T12:00:37+00:00January 7th, 2026|Endpoints News|
Rakuten Medical raises $100M for photoimmunotherapy platformnews2026-01-07T12:00:06+00:00January 7th, 2026|Endpoints News|
Soley emerges with $200M Series C and broad pipeline for ‘stress clock’news2026-01-07T11:30:08+00:00January 7th, 2026|Endpoints News|
Meanwell and Maraganore get $80M for cardio prevention biotech Corseranews2026-01-07T11:00:31+00:00January 7th, 2026|Endpoints News|
Cancer biotech Disco lines up Amgen as first pharma partnernews2026-01-07T10:00:58+00:00January 7th, 2026|Endpoints News|
Relation, Deerfield to form new companies from discovered drug targetsnews2026-01-07T06:00:17+00:00January 7th, 2026|Endpoints News|
Drugmakers frustrated by vaccine schedule overhaulnews2026-01-06T21:15:01+00:00January 6th, 2026|Endpoints News|
